Flualprazolam
Structural formula | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
Non-proprietary name | Flualprazolam | |||||||||
other names |
|
|||||||||
Molecular formula | C 17 H 12 ClFN 4 | |||||||||
External identifiers / databases | ||||||||||
|
||||||||||
Drug information | ||||||||||
Drug class | ||||||||||
properties | ||||||||||
Molar mass | 326.77 g · mol -1 | |||||||||
Physical state |
firmly |
|||||||||
safety instructions | ||||||||||
|
||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Flualprazolam is a chemical compound from the benzodiazepine group , which was developed by Upjohn (now part of Pfizer ) in the 1970s , but was never marketed commercially. However, it has been offered on the Internet as a designer drug or legal high since around 2018 .
One can Flualprazolam than the 2'- fluoro - derivative of alprazolam see or as the fluorine instead of chlorine analogue of triazolam . Similar to this, it has a strong hypnotic , sedative and anxiolytic effect. The estimated equivalent dose of 10 mg diazepam is 0.25-0.5 mg.
Individual evidence
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ↑ Patent US3987052 : 6-Phenyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepines. Filed on October 29, 1969 , published on October 19, 1976 , Applicant: Upjohn Co, Inventor: Jackson B. Hester, Jr
- ↑ Waters, Manchester, Maskell, Haider, Haegeman: The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines . In: Science & Justice . 58, No. 3, 2017, pp. 219–225. PMID 29685303 .
- ↑ Jolanta B. Zawilska, Jakub Wojcieszak: An expanding world of new psychoactive substances-designer benzodiazepines . In: NEUTOX . 73, 2019, pp. 8-16. PMID 30802466 .
- ^ Bjoern Moosmann and Volker Auwärter: Designer Benzodiazepines: Another Class of New Psychoactive Substances . In: Handbook of Experimental Pharmacology . 252, 2018, pp. 383-410. PMID 30367253 .
- ↑ Emil Chetraru, Alice Ameline, Laurie Gheddar, Jean-Sébastien Raul, Pascal Kintz: Les designer benzodiazepines: qu'en sait-on aujourd'hui? Designer benzodiazepines: What do we know about them? . In: Toxicologie Analytique et Clinique . 30, No. 1, 2018. doi : 10.1016 / j.toxac.2017.12.001 .